Latest news with #BSE500
Time of India
20 hours ago
- Business
- Time of India
Nilesh Shetty stays cautious; 3 sectors see largest allocations in value portfolio
(You can now subscribe to our (You can now subscribe to our ETMarkets WhatsApp channel , Portfolio Manager,, says the largest allocation in Quantum's value portfolio remains banking, IT services , consumer discretionary, and within financial services, a large allocation goes to the insurance space. Shetty is moving away from certain sectors and does not believe consumer staples still offer value. They have zero allocation there and still do not believe capital goods offer value. The valuations in the capital goods sector is the same as consumer staples or even higher in most cases. Given the cyclicality of the sector, Shetty does not think those valuations will sustain and expects a negative surprise started correcting in September of 2024 and the primary construct then was that there has been a significant disconnect between valuations and earnings growth and that has not materially changed. Even in the March quarter results, cumulative earnings growth for the BSE 500 was in low single digits. The rally after that, especially after the ceasefire where at least last month, the smallcap index rose 10%, has been very surprising and that again has created that disconnect between valuations and underlying remain very fairly cautious. There are pockets of opportunity and the largest pocket remains private sector banks. They trade substantially below their long-term valuations. The other big opportunity remains insurance as well as IT services. Now IT services is not a near-term story. It may be perhaps a two-year or a three-year story where you may have to wait for the discretionary spend in the US to pick up and the valuations remain comfortable. Our largest allocation in the value portfolio currently remains banking, IT services, consumer discretionary, and within financial services, we have a large allocation to insurance that is the obvious place where valuations look very comfortable, that is where our largest allocation is. But unlike the market, we also prefer IT services right now. We think there is significant opportunity if you are a patient investor there and we have been slightly ahead of the curve in the insurance space and we bought it when there was significant disconnect between valuations and where we think long-term fundamentals for the sector are slightly away from the market in certain sectors; we do not believe consumer staples still offer value. We have zero allocation there and we still do not believe capital goods offer value. The valuations in the capital goods sector is the same as consumer staples or even higher in most cases. Given the cyclicality of the sector, I do not think those valuations will sustain and investors may see a negative surprise there.
&w=3840&q=100)
Business Standard
6 days ago
- Business
- Business Standard
Concord Biotech share price pops 6% on healthy Q4 nos; profit zooms 48% YoY
Concord Biotech share price: Shares of biopharmaceutical company Concord Biotech were in demand on the last trading day of the week i.e. Friday, with the scrip rallying up to 5.64 per cent to an intraday high of ₹1,761 per share. By 10:10 AM, Concord Biotech share price was off day's high but continued to trade higher, up 4.43 per cent higher at ₹1,740.75. In comparison, BSE Sensex was down 0.13 per cent at 81,527.12 levels. Why did Concord Biotech share price rise? Concord Biotech share price rose on the back of a healthy March quarter of financial year 2025 (Q4FY25) results. The company's profit climbed 47.8 per cent year-on-year (Y-o-Y) to ₹140 crore in the March quarter of FY25, from ₹95 crore in the March quarter of FY24. Concord Biotech's revenue from operations surged 34.8 per cent Y-o-Y to ₹429.9 crore in Q4FY25, from ₹319 crore in the same quarter a year ago. At the operating level, the company's earnings before interest, tax, depreciation and amortisation (Ebitda) zoomed 41.8 per cent Y-o-Y to ₹190.4 crore versus ₹134.3 crore a year ago. Concord Biotech dividend The Board has recommended a dividend of ₹10.70 per equity share of face value of ₹1 each fully paid up for FY25, subject to approval by shareholders of the Company at the ensuing AGM. About Concord Biotech Concord Biotech, founded in 2000, is a research-driven biopharmaceutical company specialising in the production of Active Pharmaceutical Ingredients (APIs) through fermentation and semi-synthetic processes, along with finished formulations. Initially a single-product entity, Concord has evolved into a comprehensive solutions provider, offering a broad range of products across various therapeutic segments. The company has established a global presence, distributing its products in over 70 countries, including key markets like the USA, Europe, Japan, and Latin America, while also maintaining a major footprint in India. Through strategic partnerships with leading global pharmaceutical firms, Concord continues to expand its reach and product offerings in both APIs and finished formulations. The Dholka facility, established in 2000, focuses on API production and has earned numerous regulatory certifications, including from USFDA, EUGMP, and PMDA. The Valthera facility, launched in 2016, manufactures a wide range of oral solids and liquids, with plans to expand into injectable formulations. The newest addition, the Limbasi facility, established in 2021, is dedicated to API production, with advanced capabilities in fermentation and downstream processing. The market capitalisation of Concord Biotech is ₹18,682 crore, according to BSE. The company falls under the BSE 500 category.
Economic Times
7 days ago
- Business
- Economic Times
Turnaround stocks: IFCI, Shree Renuka Sugars among six BSE 500 stocks to swing to profit in Q4
Despite their strong quarterly turnarounds, stock market performance in CY2025 has been mixed for these six companies. Six BSE 500 companies, including CreditAccess Grameen and IFCI, reported profits in Q4FY25 after losses in the previous quarter. While CreditAccess Grameen and IFCI have seen positive stock returns in CY2025, others like Mahindra Lifespace Developers have lagged. Experts suggest accumulating Mahindra Life and Nuvoco long-term, favoring Balrampur Chini over Shree Renuka Sugars. Tired of too many ads? Remove Ads Mixed CY2025 stock returns Tired of too many ads? Remove Ads What to do with them? As the Q4FY25 earnings season is set to culminate this week, six listed companies in the BSE 500 index have scripted a strong turnaround, reporting profits in the reported quarter after losses in the previous quarter. The notable names which have delivered a remarkable shift in performance include CreditAccess Grameen Mahindra Lifespace Developers , Nuvoco Vistas, and Shree Renuka Sugars As of May 28, 2025, 461 companies in the BSE 500 index declared their quarterly Grameen saw a striking reversal, posting a profit of Rs 47.21 crore in Q4FY25 compared to a loss of Rs 99.52 crore in Q3. IFCI also swung to a profit of Rs 260.43 crore from a loss of Rs 8.74 crore. Similarly, Graphite India turned profitable with Rs 49 crore versus a Rs 21 crore QoQ loss. As for Mahindra Lifespace Developers, the real estate company reported Rs 85.09 crore in earnings after a Rs 22.47 crore and building material company Nuvoco Vistas posted Rs 165.54 crore in Q4 profits against a loss of Rs 61 crore, while Shree Renuka Sugars recovered from a massive Rs 203.70 crore loss in Q3FY25 to post Rs 93.10 crore in net profit in the quarter under their strong quarterly turnarounds, stock market performance in CY2025 has been mixed for these companies. CreditAccess Grameen has rewarded investors with a 33.69% return so far this year, and IFCI is up 12.78%. However, others have lagged—Graphite India is down 5.84%, Mahindra Lifespace Developers has slipped 20.57%, Nuvoco Vistas is nearly flat with a marginal 0.06% uptick, and Shree Renuka Sugars has declined 15.89%, indicating investor caution despite earnings Bathini, Director-Equity Strategy at WealthMills Securities, summed up the Q4 season as a decent quarter with no negative surprises considering the domestic and global uncertainties. In his view, all six stocks are "decent" CreditAccess, he said that the company's performance is improving. "BFSI as a sector is doing well, and NIMs are gradually getting better. The RBI policy announcements could act as a trigger if rates are cut," he said. He declined to recommend the Mahindra Life and Nuvoco, he suggested accumulation with a long-term view. As for Renuka, he said his top bet in the sugar sector is the "sector bellwether" Balrampur Chini. He has an 'Avoid' view on state-run on the growth story of IFCI, Share. Market expert Om Ghawalkar said that the turnaround came on the back of strategic divestments and a capital infusion by the government. Although the revenue of this state-run company dropped 41.6% YoY due to elevated NPAs and ongoing consolidation, the improved bottom line has powered a strong market reaction with the stock rallying 60% this for Shree Renuka Sugars, growth in ethanol sales and tighter cost control were key drivers, this analyst said. "Despite a slight decline in annual revenue, operational improvements helped narrow full-year losses. The stock is in a clear uptrend and has gained nearly 20% while trading above key moving averages," he added.: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)
Time of India
7 days ago
- Business
- Time of India
Turnaround stocks: IFCI, Shree Renuka Sugars among six BSE 500 stocks to swing to profit in Q4
Mixed CY2025 stock returns Live Events What to do with them? (You can now subscribe to our (You can now subscribe to our ETMarkets WhatsApp channel As the Q4FY25 earnings season is set to culminate this week, six listed companies in the BSE 500 index have scripted a strong turnaround, reporting profits in the reported quarter after losses in the previous quarter. The notable names which have delivered a remarkable shift in performance include CreditAccess Grameen Mahindra Lifespace Developers , Nuvoco Vistas, and Shree Renuka Sugars As of May 28, 2025, 461 companies in the BSE 500 index declared their quarterly Grameen saw a striking reversal, posting a profit of Rs 47.21 crore in Q4FY25 compared to a loss of Rs 99.52 crore in Q3. IFCI also swung to a profit of Rs 260.43 crore from a loss of Rs 8.74 crore. Similarly, Graphite India turned profitable with Rs 49 crore versus a Rs 21 crore QoQ loss. As for Mahindra Lifespace Developers, the real estate company reported Rs 85.09 crore in earnings after a Rs 22.47 crore and building material company Nuvoco Vistas posted Rs 165.54 crore in Q4 profits against a loss of Rs 61 crore, while Shree Renuka Sugars recovered from a massive Rs 203.70 crore loss in Q3FY25 to post Rs 93.10 crore in net profit in the quarter under their strong quarterly turnarounds, stock market performance in CY2025 has been mixed for these companies. CreditAccess Grameen has rewarded investors with a 33.69% return so far this year, and IFCI is up 12.78%. However, others have lagged—Graphite India is down 5.84%, Mahindra Lifespace Developers has slipped 20.57%, Nuvoco Vistas is nearly flat with a marginal 0.06% uptick, and Shree Renuka Sugars has declined 15.89%, indicating investor caution despite earnings Bathini, Director-Equity Strategy at WealthMills Securities, summed up the Q4 season as a decent quarter with no negative surprises considering the domestic and global uncertainties. In his view, all six stocks are "decent" CreditAccess, he said that the company's performance is improving. "BFSI as a sector is doing well, and NIMs are gradually getting better. The RBI policy announcements could act as a trigger if rates are cut," he said. He declined to recommend the Mahindra Life and Nuvoco, he suggested accumulation with a long-term view. As for Renuka, he said his top bet in the sugar sector is the "sector bellwether" Balrampur Chini. He has an 'Avoid' view on state-run on the growth story of IFCI, Share. Market expert Om Ghawalkar said that the turnaround came on the back of strategic divestments and a capital infusion by the government. Although the revenue of this state-run company dropped 41.6% YoY due to elevated NPAs and ongoing consolidation, the improved bottom line has powered a strong market reaction with the stock rallying 60% this for Shree Renuka Sugars, growth in ethanol sales and tighter cost control were key drivers, this analyst said. "Despite a slight decline in annual revenue, operational improvements helped narrow full-year losses. The stock is in a clear uptrend and has gained nearly 20% while trading above key moving averages," he added.: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)
Economic Times
28-05-2025
- Business
- Economic Times
BSE 500 stocks rally up to 74% in a month, but 292 still languish up to 64% below peak
The broader BSE 500 index has posted a strong performance over the past month, rallying more than 12%, with individual stocks soaring as much as 74%. Despite this impressive run, an ETMarkets analysis reveals that 292 stocks are still trading at least 20% below their 52-week highs—potentially presenting attractive opportunities for investors. ADVERTISEMENT In the list are 15 stocks that have corrected by 50% or more while 50 counters have fallen between 40% and 49%. Over a 100 counters have slipped between 39% and 30% and the remaining 138 of them are down between 29% and 20%. Domestic stock markets have remained jittery since October amid a host of factors like high valuations, 'Sell India Buy China' trade and Donald Trump's assuming charge as the US President. In the run-up to April 2, which the Trump administration referred to as the 'Liberation Day', volatility shot-up and global markets fell. Markets have stablised post April 9 following a pause on the reciprocal tariffs until July. Notwithstanding this, volatility has stood its ground and fear gauge India VIX is still 39% higher in the past one stocks with highest cuts include Sterling and Wilson Renewable Energy, Siemens and Punjab & Sind Bank (PSB) which have fallen by 64%, 60% and 59%, respectively. Others like Adani Green Energy, Network 18 Media & Investments, ITI, Titagarh Rail Systems, MMTC, Vedant Fashions, Tejas Networks, Route Mobile, Relaxo Footwears, Easy Trip Planners, UCO Bank and HFCL are down between 53% and 50%.Not all can be brushed under the sentiment carpet as individual stocks could be down because of company specific reasons and market mood may have only accentuated the fall. IndusInd Bank, which is grappling under governance issues and Aditya Birla Fashion and Retail's (ABFRL) demerger leading to price adjustments are cases in widely tracked stocks which are currently down between 20% and 49% are Birla Soft, Adani Total Gas, Indian Renewable Energy Development Agency (IREDA), PVR Inox, Honasa Consumer (mamaearth), Indian Railway Finance Corporation (IRFC), Tata Motors, Cochin Shipyard, Trent, Adani Enterprises, Asian Paints and Bajaj Auto. ADVERTISEMENT Notwithstanding the rally, BSE 500 is still 7.4% from its peak of 38,740.08 and market experts expect a bumpy ride laden with volatility in the run-up to the monthly expiry on Thursday and the Reserve Bank of India (RBI) monetary policy advising caution in the pockets which have seen sharp rally like PSU and defence. ADVERTISEMENT Analyst VK Vijayakumar, Chief Investment Strategist, Geojit Investments the market to likely consolidate around the current levels in the near-term. "A sustained rally will happen only when leading indicators suggest revival in earnings growth. Since mutual funds are sitting on sizeable cash any dip will be bought into and high valuations will trigger selling on rallies," he are advised to ride the volatility via stock specific approach, say experts. ADVERTISEMENT Aamar Deo Singh, Senior Vice President-Equity, Commodity & Currency at Angel advises investors to buy in small tranches with a long term horizon. US yields are up amid current uncertainties and investors seem to be booking profit after the recent rally in Indian equities and moving to less risky assets, he said, decoding the current mood while suggesting sector diversification with trusted largecap names like HDFC Bank and Reliance Industries (RIL). "If you are hunting for value, this is not the market for you. Hunt for growth. There are two styles of making money, the value style and the growth style. The best of value is behind us. Being growth investors, lower interest rates with continued good growth outlook is a very good combo for growth investing. We think our time has come. (Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times) ADVERTISEMENT (You can now subscribe to our ETMarkets WhatsApp channel)
